Case studies
Takeda
Building forward-thinking digital and innovation capabilities
In 2015, Takeda Pharmaceutical Company, the largest pharmaceutical company in Japan, established a simple yet radical vision to advance the merging of science, digital, and insights to transform customer experience and improve patients’ lives. For Takeda, digital technology offers the opportunity to make a real difference in people’s lives, driving patient’s to be the CEOs of their health. As a result, the company is focused on transforming into a leader in digital health.
One of the first objectives was to identify ways to accelerate and foster innovation from within. To turn these ideas into reality, Deloitte brought together a team of pharmaceutical and digital experts who helped design four global digital initiatives. They aimed to increase digital maturity levels across Takeda’s global organisation, raise awareness about digital business opportunities, infuse external expert knowledge, and fuel internal innovative thinking by building a foundation for digital experimentation, where new ways of thinking and working can be discovered by testing and learning.
To bring this to life, Takeda held its first “Dragon’s Den” (entrepreneurs pitching their business ideas) to solicit digital patient- and customer-centric ideas from its employees in its Europe/Canada region. Deloitte helped Takeda evaluate the ideas, designed and ran a Digital Experiment Bootcamp to assist the chosen teams in developing their digital ideas into minimally viable prototypes, and brought deep industry and digital expertise to help Takeda assess the ideas’ potential for globalisation. Deloitte and Takeda have continued to work together as the experimentation process has been rolled out to Takeda’s Emerging Markets and in Japan.
Across the projects, Deloitte’s team in Switzerland collaborated closely with Deloitte colleagues from the US, Germany, Israel, Japan and Korea, leveraging both our global network and our digital innovation and start-up capabilities.
Now is a transformative time for pharma, thanks in large part to the digital and technological revolution of today, and how it is converging with our industry. We endeavour to embed digital into our collective DNA to make it core to everything we do at Takeda. Deloitte’s expertise in this field is key in helping us achieve our transformative journey.
— Bruno Villetelle, Chief Digital Officer, Takeda
This client story is from the Deloitte Switzerland Annual Review 2016
See more of our client stories
Takeda
Building forward-thinking digital and innovation capabilities
Nespresso
Accelerating organic growth in a B2B environment
Philip Morris International (PMI)
Embarking on an innovation learning journey
EFG International
Comprehensive transaction support for landmark transformational Swiss private banking combination
General Electric
Delivering a complex divestiture
Syngenta AG
Business Transformation
J. Safra Sarasin Group
Using advanced reporting and data analytics to provide added value
Swiss Customs Administration
Developing a sustainable IT transformation roadmap
UNHCR
Strengthening Leadership in the Humanitarian Sector
Ascensia Diabetes Care Holdings
Implementing a successful global structure
Société Générale Private Banking (Suisse) SA
Delivering a distinctive audit through constant and open communication
Canton of Zurich
Process optimisation and digitalisation for the school districts of Zurich
Visit our interactive Annual Review
Find out on how Deloitte is making an impact to our clients, our people and society.